Long-term clinical outcomes of AST-021p, an HSP90 peptide vaccine, in advanced solid tumors: Follow-up results of the phase I CornerStone-002 trial

AST-021p - Aston Sci.

K.H. Park1; E.J. Kang2; K. Lee2; I. Kim3; J.W. Kim1; J.H. Kim1; S. Lee1; J. Lee1; K. Shin3; S.J. Park3; J. Kim3; M. HUANG4; W. Kim4; H. Jung4

Oct 4, 2025